About Biomeme
Biomeme is a company based in Philadelphia (United States) founded in 2013.. Biomeme has raised $6.2 million across 7 funding rounds from investors including European Union, EIC Fund and Ben Franklin Technology Partners. Biomeme has completed 1 acquisition, including Predigen. Biomeme offers products and services including Franklin ISP, Franklin Your Platform, and Tests Pipeline. Biomeme operates in a competitive market with competitors including DermTech, Inflammatix, MeMed, GenMark Diagnostics and Sunbird Bio, among others.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.2 M (USD)
in 7 rounds
-
Latest Funding Round
$4.51 M (USD), Series A
May 01, 2017
-
Investors
European Union
& 3 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomeme
Biomeme offers a comprehensive portfolio of products and services, including Franklin ISP, Franklin Your Platform, and Tests Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable system for efficient molecular testing in remote areas.
Streamlines collaborative research with advanced diagnostics tools.
Facilitates rapid analysis for infectious disease detection.
Unlock access to complete
Funding Insights of Biomeme
Biomeme has successfully raised a total of $6.2M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $4.51 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series A — $4.5M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2017 | Amount | Series A - Biomeme | Valuation |
investors |
|
| Sep, 2016 | Amount | Grant - Biomeme | Valuation |
investors |
|
| Jun, 2016 | Amount | Grant - Biomeme | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biomeme
Biomeme has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Ben Franklin Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Founded Year | Domain | Location | |
|
Startup accelerator
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biomeme
Biomeme has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Predigen. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene expression signatures are developed for disease diagnostics.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Biomeme
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biomeme Comparisons
Competitors of Biomeme
Biomeme operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DermTech, Inflammatix, MeMed, GenMark Diagnostics and Sunbird Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Adhesive patch biopsies for skin cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized MRI platforms for clinical diagnostics are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biomeme
Frequently Asked Questions about Biomeme
When was Biomeme founded?
Biomeme was founded in 2013.
Where is Biomeme located?
Biomeme is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Biomeme a funded company?
Biomeme is a funded company, having raised a total of $6.2M across 7 funding rounds to date. The company's 1st funding round was a Grant of $55.93K, raised on Jul 15, 2013.
What does Biomeme do?
Biomeme was founded in 2013 in Philadelphia, United States, within the biotechnology sector. A smartphone-based platform for DNA diagnostics is provided, enabling real-time qPCR through a docking station, sample preparation with targeted test kits, and result analysis via a mobile app. Operations focus on pathogen identification by DNA or RNA signatures, with initial applications directed toward sexually transmitted disease panels.
Who are the top competitors of Biomeme?
Biomeme's top competitors include Visby Medical, Inflammatix and DermTech.
What products or services does Biomeme offer?
Biomeme offers Franklin ISP, Franklin Your Platform, and Tests Pipeline.
How many acquisitions has Biomeme made?
Biomeme has made 1 acquisition, including Predigen.
Who are Biomeme's investors?
Biomeme has 4 investors. Key investors include European Union, EIC Fund, Ben Franklin Technology Partners, and Dreamit.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.